ArticleHaematologica2013

Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.

Ruben A Ferrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.